Authors:
E. Marco de Lucas, K. González Mandly, S. Sánchez, S. Gutiérrez, C. Díez, M. Pelaz, G. Blanco, R. Pellón, J. Jordá; Santander/ES
References
1. Sandoval C, et al. Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR Am J Neuroradiol 2003;24:1887-90.
2. Buonanno F, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51(5):1369-1376.
3. Fischer MJ, et al. Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR Am J Neuroradiol 2005:1686-1689.
4. Rollins N, et al. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 2004; 25:1688-95.
5. Ziereisen F, et al. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features. Pediatr Radiol DOI 10.1007/s00247-005-0015-z
6. Küker W, et al. Transient encephalopathy after intrathecal methotrexate chemotherapy: diffusion-weighted MRI. Journal of Neuro-Oncology 2005;73:47-49.